Summary
The pharmacokinetics of prednisolone elimination have been studied in both arthritic patients and normal volunteers using tritiated prednisolone alone, and in conjunction with unlabelled prednisolone in doses of 0.15 mg·kg−1 and 0.3 mg·kg−1 body weight. With increasing dose there is prolongation of the plasma half-life and increase in the volume of distribution and plasma clearance of prednisolone. It is proposed that these changes in pharmacokinetic parameters may be associated with non-linear binding of the steroid to plasma proteins.
Similar content being viewed by others
References
Coffey, J.J., Bullock, F.J., Schoenemann, P.T.: Numerical solution of non-linear pharmacokinetic equations: Effects of plasma protein binding on drug distribution and elimination. J. Pharm. Sci.60, 1623–1628 (1971)
Colburn, W.A., Buller, R.H.: Radioimmunoassay for prednisolone. Steroids21, 833–846 (1973)
D'Arcy, P.F., Griffin, J.P., Jenkins, J.S., Kirk, W.F., Peacock, A.W.C.: Sustained release formulation of prednisolone administered orally to man. J. Pharm. Sci.60, 1028–1033 (1971)
Dayton, P.G., Cucinell, S.A., Weiss, M., Perel, J.M.: Dose-dependence of drug plasma level decline in dogs. J. Pharmacol. Exp. Ther.158, 305–316 (1967)
DiSanto, A.R., DeSante, K.A.: Bioavailability and pharmacokinetics of prednisone in humans. J. Pharm. Sci.64, 109–112 (1975)
DiSanto, A.R., Wagner, J.G.: Potential erroneous assignment of non-linear data to the classical linear two-compartment open model. J. Pharm. Sci.61, 552–555 (1972)
English, J., Chakraborty, J., Marks, V.: A competitive protein binding method for plasma prednisolone assay. Ann. Clin. Biochem.11, 11–14 (1974)
Fell, P.J., Stevens, M.T.: Pharmacokinetics — uses and abuses. Europ. J. Clin. Pharmacol.8, 241–248 (1975)
Fotherby, K., James, F.: Metabolism of synthetic steroids. Advances in Steroid Biochemistry and Pharmacology,3, 124–165 (1972)
Gerber, N., Wagner, J.G.: Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of Michaelis-Menten equation. Res. Comm. Chem. Pathol. Pharmacol.3, 455 (1972)
Gibaldi, M., Perrier, D.: Pharmacokinetics. p. 45–60. New York: Marcel Dekker, Inc. 1975
Jähnchen, E., Levy, G.: Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone. Proc. Soc. Exp. Biol. Med.141, 963 (1972)
Jusko, W.J., Gretch, M.: Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metab. Rev.5, 43–140 (1976)
Jusko, W.J., Levy, G.: Pharmacokinetic evidence for saturable renal tubular reabsorption of riboflavin. J. Pharm. Sci.59, 765–772 (1970)
Kozower, M., Veatch, L., Kaplan, M.: Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J. Clin. Endocrinol. Metab.38, 407–412 (1974)
Kruger-Thiemer, E., Diller, W., Bunger, P.: Pharmacokinetic models regarding protein binding of drugs. Antimicrob. Agents Chemother.5, 183–191 (1965)
Levy, G.: Pharmacokinetics of salicylate elimination in man. J. Pharm. Sci.54, 959–967 (1965)
Lewis, G.P., Jusko, W.J., Burke, C.W., Graves, L.: Prednisone side-effects and serum protein levels. Lancet1971 II, 778–781
Meikle, A.W., Weed, J.A., Tyler, F.H.: Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunoassays. J. Clin. Endocrinol. Metab.41, 717–721 (1975)
Riegelman, S., Loo, J., Rowland, M.: Concept of a volume of distribution and possible errors in evaluation of this parameter. J. Pharm. Sci.57, 128–133 (1968)
Sandberg, D.H., Bacallao, C.Z., Cleveland, W.W.: Measurement of plasma prednisolone by a competitive protein binding assay. Biochem. Med.4, 383–390 (1970)
Swinscow, T.D.V.: Statistics at square one. XVII — Some non-parametric tests. Brit. Med. J.1976 III, 632–634
Sullivan, T.J., Sakmar, E., Albert, K.S., Blair, D.C., Wagner, J.G.: In vitro and in vivo availability of commercial prednisone tablets. J. Pharm. Sci.64, 1723–1725 (1975)
Sullivan, T.J., Stoll, R.G., Sakmar, E., Blair, D.C., Wagner, J.G.: In vitro and in vivo availability of some commercial prednisolone tablets. J. Pharmacokinet. Biopharm.2, 29–41 (1974)
Vermeulen, A.: The metabolism of 4-14C prednisolone. J. Endocrinol.18, 278–291 (1959)
Wilson, C.G., Ssendagire, R., May, C.S., Paterson, J.W.: Measurement of plasma prednisolone in man. Brit. J. clin. Pharmacol.2, 321–325 (1975)
Yates, F.E., Brennan, R.D.: Study in the mammalian glucocorticoid system by computer simulation. Technical report no. 320-3228, IBM Data Processing Division (1967)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pickup, M.E., Lowe, J.R., Leatham, P.A. et al. Dose dependent pharmacokinetics of prednisolone. Eur J Clin Pharmacol 12, 213–219 (1977). https://doi.org/10.1007/BF00609864
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609864